Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.

about

Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates.Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.

P2860

Q33746975-C3E80D21-92FC-4BA9-A708-CF75C9273E0B Q37085052-DC6F566D-C6BA-49C3-94C0-C1FD035D9ADA

P2860

Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.

Item

http://www.wikidata.org/entity/Q35847776

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Automated astatination of biom ...... s multicenter clinical trials.

@ast

Automated astatination of biom ...... s multicenter clinical trials.

@en

type

Item

label

Automated astatination of biom ...... s multicenter clinical trials.

@ast

Automated astatination of biom ...... s multicenter clinical trials.

@en

prefLabel

Automated astatination of biom ...... s multicenter clinical trials.

@ast

Automated astatination of biom ...... s multicenter clinical trials.

@en

P1476

Automated astatination of biom ...... s multicenter clinical trials.

@en

P2093

Emma Aneheim

http://www.w3.org/2001/XMLSchema#string

Holger Jensen

http://www.w3.org/2001/XMLSchema#string

Per Albertsson

http://www.w3.org/2001/XMLSchema#string

Stig Palm

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6

Enigmatic astatine.

The potential and hurdles of targeted alpha therapy - clinical trials and beyond.

Electronic Generators for the Production of Positron-Emitter Labeled Radiopharmaceuticals. Where Would PET Be Without Them?

Molecular targeted α-particle therapy for oncologic applications.

Automation synthesis modules review.

Preparation and evaluation of 211At labelled antineoplastic antibodies.

High-level production of alpha-particle-emitting (211)At and preparation of (211)At-labeled antibodies for clinical use.

Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

Radiopharmaceutical chemistry of targeted radiotherapeutics, part 1: effects of solvent on the degradation of radiohalogenation precursors by 211At alpha-particles.

P2888

srep12025

P304

12025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP12025

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tom A. Bäck

Sture Lindegren

P577

2015-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280042434

http://www.w3.org/2001/XMLSchema#string

P698

26169786

http://www.w3.org/2001/XMLSchema#string

P932

4500947

http://www.w3.org/2001/XMLSchema#string

Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.

about

P2860

P2860

Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932